|
BG96952A
|
|
Solid-form medicament based on raxatidinacetate hydrochloride
|
|
BG95775A
|
|
Method for lovastation isolatin and purification
|
|
BG94585A
|
|
Method for the preparation of an analgesic medicament
|
|
BG51386A1
|
|
antitumour preparation
|
|
BG51300A1
|
|
Method for producing of stimulation effect antibiotic
|
|
BG51277A1
|
|
Medicament form on the basis of 1,2-diphenyl-1-/4-/2-dimethyl-aminoethoxy/phenyl/-1-butene
|
|
BG50863A1
|
|
A medicamentous form on the basis of 2/p-/2-hydroxy-3-isopropylamino/propoxy/phenylacetamide
|
|
BG51399A1
|
|
N-methyl-n-(2-chlorineethyl)-2-((2-hydroxymethyl)- phenylamino)-2-phenylethylamine hydrochloride and process for the preparation thereof
|
|
BG51092A1
|
|
Process for preparing of trans-1/4-(2-dimethylaminoethoxy)phenyl/-1,2-diphenyl-1-butene hydrochloride
|
|
BG50771A1
|
|
Method for the preparation of alpha- ethyldesoxybenzoin
|
|
BG50304A1
|
|
Aproces of preparing parenteral medicinal forms of sodium-alfa-6-methylprednisolone- 21-hydrogensuccinate
|
|
BG50187A1
|
|
Solid medicinal form on the basis of ergoalkaloid derivatides
|
|
BG50095A1
|
|
Esters of 1- methyl- 10 alpha- metoxy- 9, 10- dihydro- lisergol and method for their preparation
|
|
BG49959A1
|
|
Method for preparing of vasodilative means for cerebral circulation of the blood
|
|
BG49876A1
|
|
Method for preparing of n, n- dimethylacetamide aduct d (-)- alpha- (4- ethyl- 2, 3- dioxopyperazynil) carboxamido- alpha- (4- hydroxyphenyl) acetamid- 3- 5- (1- methyl-
|
|
BG49852A1
|
|
Local medicine form
|
|
BG49551A1
|
|
Method for preparing of 21- esters of cortycosteroydes
|
|
BG49521A1
|
|
Toothpaste with a plant substance
|
|
BG49316A1
|
|
Method for preparing trihydroxyethyl rutin
|
|
BG49213A1
|
|
Derrivatives of 4- piperasinil- 6- aminopirimidiny and method for their preparation
|
